# Healthpeak Properties, Inc.: Form 10-Q for the period ended Sep 30, 2013

- Company: [Healthpeak Properties, Inc.](/companies/doc.md) (CIK 765880)
- Form: 10-Q
- Filed: 2013-11-04
- Accepted by EDGAR: Nov 4, 2013, 07:01 ET
- Period: 2013-09-30
- Accession: 0001104659-13-080260
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/765880/000110465913080260/a13-19094_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/765880/000110465913080260/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-07-01 to 2013-09-30 | $544.0m | us-gaap:Revenues |
| Revenue | 9 months, 2013-01-01 to 2013-09-30 | $1.56bn | us-gaap:Revenues |
| Interest expense | 3 months, 2013-07-01 to 2013-09-30 | $108.1m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2013-01-01 to 2013-09-30 | $326.1m | us-gaap:InterestExpense |
| Income tax | 3 months, 2013-07-01 to 2013-09-30 | $1.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2013-01-01 to 2013-09-30 | $3.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2013-07-01 to 2013-09-30 | $233.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2013-01-01 to 2013-09-30 | $677.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2013-07-01 to 2013-09-30 | $0.51 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2013-01-01 to 2013-09-30 | $1.49 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2013-07-01 to 2013-09-30 | $0.51 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2013-01-01 to 2013-09-30 | $1.49 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2013-07-01 to 2013-09-30 | 456,078,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2013-01-01 to 2013-09-30 | 455,388,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2013-01-01 to 2013-09-30 | $843.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 9 months, 2013-01-01 to 2013-09-30 | $716.9m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | at 2013-09-30 | $49.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | at 2013-09-30 | $19.89bn | us-gaap:Assets |
| Total liabilities | at 2013-09-30 | $9.04bn | us-gaap:Liabilities |
| Long-term debt | at 2013-09-30 | $8.48bn | us-gaap:LongTermDebt |
| Shareholders' equity | at 2013-09-30 | $10.64bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 65,803 characters.

### Cautionary Language Regarding Forward-Looking Statements

Statements in this Quarterly Report on Form 10-Q that are not historical factual statements are “forward-looking statements.” We intend to have our forward-looking statements covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include this statement for purposes of complying with those provisions. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectation as identified by the use of words such as “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” “forecast,” “plan,” “estimate,” “could,” “would,” “should” and other comparable and derivative terms or the negatives thereof. In addition, we, through our officers, from time to time, make forward-looking oral and written public statements concerning our expected future operations, strategies, securities offerings, growth and investment opportunities, dispositions, capital structure changes, budgets and other developments. Readers are cautioned that, while forward-looking statements reflect our good faith belief and reasonable assumptions based upon current information, we can give no assurance that our expectations or forecasts will be attained. Therefore, readers should be mindful that forward-looking statements are not guarantees of future performance and that they are subject to known and unknown risks and uncertainties that are difficult to predict. As more fully set forth under “Part I, Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012, factors that may cause our actual results to differ materially from the expectations contained in the forward-looking statements include:

(a) Changes in global, national and local economic conditions, including a prolonged period of weak economic growth;

(b) Volatility in the capital markets, including changes in interest rates and the availability and cost of capital;

(c) Our ability to manage our indebtedness level and changes in the terms of such indebtedness;

(d) The effect on healthcare providers of the automatic spending cuts enacted by Congress (“Sequestration”) on entitlement programs, including Medicare, which will, unless modified, result in future reductions in reimbursements;

(e) The ability of our operators, tenants and borrowers to conduct their respective businesses in a manner sufficient to maintain or increase their revenues and to generate sufficient income to make rent and loan payments to us and our ability to recover investments made, if applicable, in their operations;

(f) The financial weakness of some operators and tenants, including potential bankruptcies and downturns in their businesses, which results in uncertainties regarding our ability to continue to realize the full benefit of such operators’ and/or tenants’ leases;

(g) Changes in federal, state or local laws and regulations, including those affecting the healthcare industry that affect our costs of compliance or increase the costs, or otherwise affect the operations of our operators, tenants and borrowers;

(h) The potential impact of future litigation matters, including the possibility of larger than expected litigation costs, adverse results and related developments;

(i) Competition for tenants and borrowers, including with respect to new leases and mortgages and the renewal or rollover of existing leases;

(j) Our ability to negotiate the same or better terms with new tenants or operators if existing leases are not renewed or we exercise our right to replace an existing operator or tenant upon default;

(k) Availability of suitable properties to acquire at favorable prices and the competition for the acquisition and financing of those properties;

(l) The financial, legal, regulatory and reputational difficulties of significant operators of our properties;

(m) The risk that we may not be able to achieve the benefits of investments within expected time-frames or at all, or within expected cost projections;

(n) The ability to obtain financing necessary to consummate acquisitions on favorable terms;

(o) The risks associated with our investments in joint ventures and unconsolidated entities, including our lack of sole decision making authority and our reliance on our joint venture partners’ financial condition and continued cooperation; and

(p) Changes in the credit ratings on United States (“U.S.”) government debt securities or default or delay in payment by the U.S. of its obligations.

Except as required by law, we undertake no, and hereby disclaim any, obligation to update any forward-looking statements, whether as a result of new information, changed circumstances or otherwise.

The information set forth in this Item 2 is intended to provide readers with an understanding of our financial condition, changes in financial condition and results of operations. We will discuss and provide our analysis in the following order:

- Executive Summary
- 2013 Transaction Overview
- Dividends
- Critical Accounting Policies
- Results of Operations
- Liquidity and Capital Resources
- Funds from Operations (“FFO”)
- Off-Balance Sheet Arrangements
- Contractual Obligations
- Inflation
- Recent Accounting Pronouncements

### Executive Summary

We are a Maryland corporation and were organized to qualify as a self-administered real estate investment trust (“REIT”) that, together with our unconsolidated joint ventures, invests primarily in real estate serving the healthcare industry in the U.S. We acquire, develop, lease, manage and dispose of healthcare real estate, and provide financing to healthcare providers. At September 30, 2013, our portfolio of investments, including properties in our Investment Management Platform, consisted of interests in 1,163 facilities. Our Investment Management Platform represents the following joint ventures: (i) HCP Ventures III, LLC, (ii) HCP Ventures IV, LLC and (iii) the HCP Life Science ventures.

Our business strategy is based on three principles: (i) opportunistic investing, (ii) portfolio diversification and (iii) conservative financing. We actively redeploy capital from investments with lower return potential or shorter investment horizons into assets representing longer term investments with attractive risk-adjusted return potential. We make investments where the expected risk-adjusted return exceeds our cost of capital and strive to capitalize on our operator, tenant and other business relationships to grow our business.

Our strategy contemplates acquiring and developing properties on terms that are favorable to us. Generally, we prefer larger, more complex private transactions that leverage our management team’s experience and our infrastructure. We follow a disciplined approach to enhancing the value of our existing portfolio, including ongoing evaluation of potential disposition of properties that no longer fit our strategy.

We primarily generate revenue by leasing healthcare properties under long-term leases with fixed and/or inflation indexed escalators. Most of our rents and other earned income from leases are received under triple-net leases or leases that provide for substantial recovery of operating expenses; however, some of our medical office and life science leases are structured as gross or modified gross leases. Operating expenses are generally related to medical office building (“MOB”) and life science leased properties and senior housing properties managed by eligible independent contractors on our behalf (“RIDEA properties”). Accordingly, for such MOBs, life science facilities and RIDEA properties, we incur certain property operating expenses, such as real estate taxes, repairs and maintenance, property management fees, utilities, employee costs for resident care and insurance. Our growth for these assets depends, in part, on our ability to (i) increase rental income and other earned income from leases by increasing rental rates and occupancy levels; (ii) maximize tenant recoveries given underlying lease structures; and (iii) control operating and other expenses. Our operations are impacted by property specific, market specific, general economic and other conditions.

### 2013 Transaction Overview

#### Investment Transactions

During the nine months ended September 30, 2013, we made investments of $541 million, which included the following:

- On September 25, 2013, we acquired a 60-bed hospital located in Webster, Texas valued at $15 million; in exchange we sold a 62-bed hospital located in Greenfield, Wisconsin and recognized a gain of $8 million.
- On September 6, 2013, we received £129 million ($202 million) from the par payoff of our Barchester debt investments, resulting in interest income of $24 million from the acquisition-related discounts. We acquired these debt investments in two tranches: (i) £121 million at a discount for £109 million in May 2013; and (ii) £9 million at a discount for £5 million in August 2013.
- On June 25, 2013, we funded the $102 million second tranche of our 2012 mezzanine loan facility to Tandem Health Care, an affiliate of Formation Capital, as part of the recapitalization of a post-acute/skilled nursing portfolio. The funds from the second tranche were used to repay debt senior to our loan. The loan bears interest at a fixed rate of 12% and 14% per annum for the first and second transactions, respectively. The facility will have a total term of up to 63 months from the initial closing in July 2012. The mezzanine loan facility is subordinate to $443 million of senior mortgage debt.
- In March 2013, we acquired the four remaining senior housing facilities from our previously announced 2012 Blackstone JV Acquisition for $38 million.
- We funded $208 million to acquire a senior housing facility and marketable debt securities, and to fund construction and other capital projects, primarily in our life science, medical office and senior housing segments.

During the nine months ended September 30, 2013, we placed into service a 70,000 square foot building located in Mountain View, California that is 100% leased.

#### Financing Activities

On February 28, 2013, we repaid $150 million of maturing 5.625% senior unsecured notes.

### Dividends

On October 24, 2013, we announced that our Board declared a quarterly common stock cash dividend of $0.525 per share. The common stock dividend will be paid on November 19, 2013 to stockholders of record as of the close of business on November 4, 2013 and represents an annualized dividend pay rate of $2.10 per share.

### Critical Accounting Policies

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to use judgment in the application of accounting policies, including making estimates and assumptions. We base estimates on the best information available to us at the time, our experience and on various other assumptions believed to be reasonable under the circumstances. These estimates affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. If our judgment or interpretation of the facts and circumstances relating to various transactions or other matters had been different, it is possible that different accounting would have been applied, resulting in a different presentation of our condensed consolidated financial statements. From time to time, we re-evaluate our estimates and assumptions. In the event estimates or assumptions prove to be different from actual results, adjustments are made in subsequent periods to reflect more current estimates and assumptions about matters that are inherently uncertain. A summary of our critical accounting policies is included in our Annual Report on Form 10-K for the year ended December 31, 2012 in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations”; our critical accounting policies have not changed during 2013.

### Results of Operations

We evaluate our business and allocate resources among our five business segments: (i) senior housing, (ii) post-acute/skilled nursing, (iii) life science, (iv) medical office and (v) hospital. Under the senior housing, life science, post-acute/skilled nursing and hospital segments, we invest or co-invest primarily in single operator or tenant properties, through the acquisition and development of real estate, management of operations (“RIDEA”) and by debt issued by operators in these sectors. Under the medical office segment, we invest or co-invest through the acquisition and development of MOBs that are leased under gross, modified gross or triple-net leases, generally to multiple tenants, and which generally require a greater level of property management.

We use net operating income from continuing operations (“NOI”) and adjusted NOI to assess and compare property level performance, including our same property portfolio (“SPP”), and to make decisions about resource allocations and to assess and compare property level performance. We believe these measures provide investors relevant and useful information because they reflect only income and operating expense items that are incurred at the property level and present them on an unleveraged basis. We believe that net income is the most directly comparable GAAP measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net income as defined by GAAP since NOI excludes certain components from net income. Further, NOI may not be comparable to that of other REITs or real estate companies, as they may use different methodologies for calculating NOI. See Note 13 to the Condensed Consolidated Financial Statements for additional segment information and the relevant reconciliations from net income to NOI and adjusted NOI.

Operating expenses are generally related to MOB and life science leased properties and senior housing properties managed by eligible independent contractors on our behalf (RIDEA properties). We generally recover all or a portion of MOB and life science expenses from the tenants (tenant recoveries). The presentation of expenses as operating or general and administrative is based on the underlying nature of the expense. Periodically, we review the classification of expenses between categories and make revisions based on changes in the underlying nature of the expenses.

Our evaluation of results of operations by each business segment includes an analysis of our SPP and our total property portfolio. SPP information allows us to evaluate the performance of our leased property portfolio under a consistent population by eliminating changes in the composition of our portfolio of properties. We identify our SPP as stabilized properties that remained in operations and were consistently reported as leased properties or RIDEA properties for the duration of the year-over-year comparison periods presented. Accordingly, it takes a stabilized property a minimum of 12 months in operations under a consistent reporting structure to be included in our SPP. Newly acquired operating assets are generally considered stabilized at the earlier of lease-up (typically when the tenant(s) controls the physical use of at least 80% of the space) or 12 months from the acquisition date. Newly completed developments, including redevelopments, are considered stabilized at the earlier of lease-up or 24 months from the date the property is placed in service. SPP NOI excludes certain non-property specific operating expenses that are allocated to each operating segment on a consolidated basis.

### Comparison of the Three Months Ended September 30, 2013 to the Three Months Ended September 30, 2012

During the fourth quarter of 2012 and first quarter of 2013, we acquired a portfolio of 133 senior housing communities (the “Blackstone JV Acquisition”; see additional information in Note 3 to the Condensed Consolidated Financial Statements). The transaction closed in two stages: (i) 129 senior housing facilities during the fourth quarter of 2012 for $1.7 billion; and (ii) four senior housing facilities during the first quarter of 2013 for $38 million. The results of operations from the acquisitions are reflected in our condensed consolidated financial statements from those respective dates.

#### Segment NOI and Adjusted NOI

The tables below provide selected operating information for our SPP and total property portfolio for each of our five business segments. Our consolidated SPP consists of 923 properties representing properties acquired or placed in service and stabilized on or prior to January 1, 2012 and that remained in operations under a consistent reporting structure through September 30, 2013. Our consolidated total property portfolio represents 1,089 and 950 properties at September 30, 2013 and 2012, respectively, and excludes properties classified as discontinued operations.

Results are as of and for the three months ended September 30, 2013 and 2012 (dollars and square feet in thousands except per capacity data):

### Senior Housing

|  | SPP 2013 | 2012 | Change | Total Portfolio 2013 | 2012 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $114,868 | $114,661 | $207 | $149,443 | $114,661 | $34,782 |
| Resident fees and services | 37,589 | 36,076 | 1,513 | 37,589 | 36,076 | 1,513 |
| Total revenues | 152,457 | 150,737 | 1,720 | 187,032 | 150,737 | 36,295 |
| Operating expenses | (24,027) | (24,248) | 221 | (24,641) | (24,872) | 231 |
| NOI | 128,430 | 126,489 | 1,941 | 162,391 | 125,865 | 36,526 |
| Straight-line rents | (3,464) | (6,985) | 3,521 | (10,806) | (6,985) | (3,821) |
| DFL accretion | (2,440) | (5,121) | 2,681 | (2,440) | (5,121) | 2,681 |
| Amortization of above and below market lease intangibles, net | (257) | (358) | 101 | (148) | (358) | 210 |
| Adjusted NOI | $122,269 | $114,025 | $8,244 | $148,997 | $113,401 | $35,596 |
| Adjusted NOI % change |  |  | 7.2% |  |  |  |
| Property count(2) | 311 | 311 |  | 445 | 311 |  |
| Average capacity (units)(3) | 35,306 | 35,313 |  | 45,396 | 35,313 |  |
| Average annual rent per unit(4) | $13,871 | $12,929 |  | $13,197 | $12,929 |  |

(1) Represents rental and related revenues and income from direct financing leases (“DFLs”).

(2) From our past presentation of SPP for the three months ended September 30, 2012, we removed a senior housing property from SPP that was sold.

(3) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

(4) Average annual rent per unit includes operating income from properties under a RIDEA structure, which are included based on NOI.

*SPP NOI and Adjusted NOI.* SPP NOI increased primarily as a result of rent increases related to new leases or leases not recognized on a straight-line basis (cash basis) and increased NOI from RIDEA properties; these increases were partially offset by a decline in DFL income as a result of a 14-property DFL portfolio (the “DFL Portfolio”) that was placed on a cash basis during the three months ended September 30, 2013. SPP adjusted NOI improved primarily as a result of annual rent increases including increases from properties that were previously transitioned from Sunrise to other operators and increased NOI from RIDEA properties.

*Total Portfolio NOI and Adjusted NOI.* In addition to the impact of our SPP, our total portfolio NOI and adjusted NOI primarily increased as a result of our Blackstone JV Acquisition.

### Post-Acute/Skilled Nursing

|  | SPP 2013 | 2012 | Change | Total Portfolio 2013 | 2012 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $138,289 | $135,183 | $3,106 | $138,289 | $135,183 | $3,106 |
| Operating expenses | (146) | (154) | 8 | (647) | (154) | (493) |
| NOI | 138,143 | 135,029 | 3,114 | 137,642 | 135,029 | 2,613 |
| Straight-line rents | (13) | (155) | 142 | (13) | (155) | 142 |
| DFL accretion | (17,382) | (18,312) | 930 | (17,382) | (18,312) | 930 |
| Amortization of above and below market lease intangibles, net | 11 | 11 | — | 11 | 11 | — |
| Adjusted NOI | $120,759 | $116,573 | $4,186 | $120,258 | $116,573 | $3,685 |
| Adjusted NOI % change |  |  | 3.6% |  |  |  |
| Property count(2) | 312 | 312 |  | 312 | 312 |  |
| Average capacity (beds)(3) | 39,826 | 39,850 |  | 39,826 | 39,850 |  |
| Average annual rent per bed | $12,142 | $11,715 |  | $12,142 | $11,715 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) From our past presentation of SPP for the three months ended September 30, 2012, we removed a post-acute/skilled nursing property from SPP that was sold.

(3) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

*NOI and Adjusted NOI.* SPP and total portfolio NOI and adjusted NOI primarily increased as a result of annual rent escalations.

### Life Science

|  | SPP 2013 | 2012 | Change | Total Portfolio 2013 | 2012 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $60,469 | $60,204 | $265 | $61,891 | $61,797 | $94 |
| Tenant recoveries | 10,181 | 9,267 | 914 | 10,640 | 9,397 | 1,243 |
| Total revenues | 70,650 | 69,471 | 1,179 | 72,531 | 71,194 | 1,337 |
| Operating expenses | (12,182) | (10,516) | (1,666) | (14,091) | (11,791) | (2,300) |
| NOI | 58,468 | 58,955 | (487) | 58,440 | 59,403 | (963) |
| Straight-line rents | (2,942) | (2,827) | (115) | (1,864) | (3,010) | 1,146 |
| Amortization of above and below market lease intangibles, net | (39) | 135 | (174) | (43) | 123 | (166) |
| Lease termination fees | (181) | (175) | (6) | (181) | (175) | (6) |
| Adjusted NOI | $55,306 | $56,088 | $(782) | $56,352 | $56,341 | $11 |
| Adjusted NOI % change |  |  | (1.4)% |  |  |  |
| Property count | 105 | 105 |  | 111 | 110 |  |
| Average occupancy | 91.9% | 90.1% |  | 91.8% | 89.5% |  |
| Average occupied square feet | 6,234 | 6,112 |  | 6,496 | 6,268 |  |
| Average annual rent per occupied square foot | $43 | $44 |  | $43 | $43 |  |

During the three months ended September 30, 2013, 108,000 square feet of new and renewal leases commenced at an average annual base rent of $23.68 per square foot compared to 64,000 square feet of expiring and terminated leases with an average annual base rent of $30.25 per square foot.

### Medical Office

|  | SPP 2013 | 2012 | Change | Total Portfolio 2013 | 2012 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $66,224 | $66,787 | $(563) | $73,771 | $72,344 | $1,427 |
| Tenant recoveries | 13,006 | 12,898 | 108 | 14,702 | 13,456 | 1,246 |
| Total revenues | 79,230 | 79,685 | (455) | 88,473 | 85,800 | 2,673 |
| Operating expenses | (30,936) | (31,116) | 180 | (36,218) | (34,948) | (1,270) |
| NOI | 48,294 | 48,569 | (275) | 52,255 | 50,852 | 1,403 |
| Straight-line rents | (60) | (982) | 922 | (299) | (1,331) | 1,032 |
| Amortization of above and below market lease intangibles, net | 146 | 79 | 67 | 282 | 148 | 134 |
| Lease termination fees | (24) | — | (24) | (24) | — | (24) |
| Adjusted NOI | $48,356 | $47,666 | $690 | $52,214 | $49,669 | $2,545 |
| Adjusted NOI % change |  |  | 1.4% |  |  |  |
| Property count(1) | 184 | 184 |  | 208 | 205 |  |
| Average occupancy | 90.0% | 91.4% |  | 89.8% | 91.2% |  |
| Average occupied square feet | 11,397 | 11,576 |  | 12,754 | 12,605 |  |
| Average annual rent per occupied square foot | $28 | $27 |  | $28 | $27 |  |

(1) From our past presentation of SPP for the three months ended September 30, 2012, we removed a MOB that was placed into redevelopment in 2013, which no longer meets our criteria for SPP as of the date it was placed into redevelopment.

*Total Portfolio NOI and Adjusted NOI.* Total portfolio NOI and adjusted NOI increased primarily as a result of the impact of our MOB acquisitions in 2012.

During the three months ended September 30, 2013, 492,000 square feet of new and renewal leases commenced at an average annual base rent of $21.42 per square foot compared to 491,000 square feet of expiring and terminated leases with an average annual base rent of $23.36 per square foot.

### Hospital

|  | SPP 2013 | 2012 | Change | Total Portfolio 2013 | 2012 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $13,060 | $13,078 | $(18) | $14,447 | $13,842 | $605 |
| Tenant recoveries | 644 | 573 | 71 | 644 | 572 | 72 |
| Total revenues | 13,704 | 13,651 | 53 | 15,091 | 14,414 | 677 |
| Operating expenses | (972) | (886) | (86) | (972) | (888) | (84) |
| NOI | 12,732 | 12,765 | (33) | 14,119 | 13,526 | 593 |
| Straight-line rents | 686 | (108) | 794 | 371 | (249) | 620 |
| Amortization of above and below market lease intangibles, net | (317) | (87) | (230) | (342) | (112) | (230) |
| Adjusted NOI | $13,101 | $12,570 | $531 | $14,148 | $13,165 | $983 |
| Adjusted NOI % change |  |  | 4.2% |  |  |  |
| Property count(1) | 11 | 11 |  | 13 | 12 |  |
| Average capacity (beds)(2) | 1,448 | 1,453 |  | 1,535 | 1,484 |  |
| Average annual rent per bed | $38,876 | $37,043 |  | $39,401 | $37,879 |  |

(1) From our past presentation of SPP for the three months ended September 30, 2012, we removed five hospitals from SPP that were sold or classified as held for sale.

(2) Represents capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented. Certain operators in our hospital portfolio are not required under their respective leases to provide operational data.

*SPP NOI and Adjusted NOI.* SPP adjusted NOI increased primarily as a result of a new lease on our Plano hospital.

*Total Portfolio NOI and Adjusted NOI.* In addition to the impact of our SPP, our total portfolio NOI and adjusted NOI primarily increased as a result of rents on our Fresno hospital that was placed in service in January 2013.

#### Other Income and Expense Items

#### Interest income

Interest income increased $32 million to $42 million for the three months ended September 30, 2013. The increase was primarily the result of interest income from the repayment of our Barchester loan in September 2013 (acquired earlier in 2013 at discounted prices) and interest earned from the second tranche of our mezzanine loan facility to Tandem Health Care (see Note 6 to the Condensed Consolidated Financial Statements for additional information).

#### Interest expense

Interest expense increased $5 million to $108 million for the three months ended September 30, 2013. The increase was primarily the result of increases in indebtedness and a decrease of capitalized interest related to assets that were under development in our life science and medical office segments and were placed in service during 2013 and 2012. These increases were partially offset by a reduction in interest rates.

Our exposure to expense fluctuations related to our variable rate indebtedness is substantially mitigated by our interest rate swap contracts. For a more detailed discussion of our interest rate risk, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 3.

The table below sets forth information with respect to our debt, excluding premiums and discounts (dollars in thousands):

| Balance: | As of September 30,(1) 2013 | 2012 |
| --- | ---: | ---: |
| Fixed rate | $8,185,353 | $7,813,925 |
| Variable rate | 324,902 | 40,404 |
| Total | $8,510,255 | $7,854,329 |

32

| Percent of total debt: | As of September 30,(1) 2013 | 2012 |
| --- | ---: | ---: |
| Fixed rate | 96% | 99% |
| Variable rate | 4 | 1 |
| Total | 100% | 100% |
| **Weighted average interest rate at end of period:** |  |  |
| Fixed rate | 5.21% | 5.49% |
| Variable rate | 1.57% | 4.53% |
| Total weighted average rate | 5.07% | 5.47% |

(1) Excludes $78 million and $85 million at September 30, 2013 and 2012, respectively, of other debt that represents non-interest bearing life care bonds and occupancy fee deposits at certain of our senior housing facilities, which have no scheduled maturities. At September 30, 2013, $72 million of variable-rate mortgages and a £137 million ($222 million) term loan are presented as fixed-rate debt as the interest payments under such debt have been swapped (pay fixed and receive float). At September 30, 2012, $87 million of variable-rate mortgages are presented as fixed-rate debt as the interest payments under such debt have been swapped (pay fixed and receive float); the interest rates for swapped debt are presented at the swapped rates.

#### Depreciation and amortization expense

Depreciation and amortization expense increased $18 million to $105 million for the three months ended September 30, 2013. The increase was primarily the result of the impact of our senior housing facility and MOB acquisitions in 2012.

#### General and administrative expenses

General and administrative expenses increased $26 million to $45 million for the three months ended September 30, 2013. The three months ended September 30, 2013 included $26.4 million of severance-related charges resulting from the termination of our former Chairman, Chief Executive Officer and President (see Note 21 to the Condensed Consolidated Financial Statements for additional information).

#### Impairments

During the three months ended September 30, 2012, we recognized an impairment of $8 million as a result of the sale a life science land parcel (see Note 20 to the Condensed Consolidated Financial Statements for additional information). No impairments were recognized during the three months ended September 30, 2013.

#### Discontinued operations

During the three months ended September 30, 2013, we sold a hospital and recognized a gain of $8 million. There were no sales of properties during the three months ended September 30, 2012.

### Comparison of the Nine Months Ended September 30, 2013 to the Nine Months Ended September 30, 2012

During the fourth quarter of 2012 and first quarter of 2013, we acquired a portfolio of 133 senior housing communities (the “Blackstone JV Acquisition”, see additional information in Note 3 to the Condensed Consolidated Financial Statements). The transaction closed in two stages: (i) 129 senior housing facilities during the fourth quarter of 2012 for $1.7 billion; and (ii) four senior housing facilities during the first quarter of 2013 for $38 million. The results of operations from the acquisitions are reflected in our condensed consolidated financial statements from those respective dates.

#### Segment NOI and Adjusted NOI

The tables below provide selected operating information for our SPP and total property portfolio for each of our five business segments. Our consolidated SPP consists of 920 properties representing properties acquired or placed in service and stabilized on or prior to January 1, 2012 and that remained in operations under a consistent reporting structure through September 30, 2013. Our consolidated total property portfolio represents 1,089 and 950 properties at September 30, 2013 and 2012, respectively, and excludes properties classified as discontinued operations.

Results are as of and for the nine months ended September 30, 2013 and 2012 (dollars and square feet in thousands except per capacity data):

### Senior Housing

|  | SPP 2013 2012 | Change | Total Portfolio 2013 | 2012 | Change |
| --- | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $346,093 $341,257 | $4,836 | $448,600 | $341,353 | $107,247 |
| Resident fees and services | 112,070 107,824 | 4,246 | 112,070 | 107,824 | 4,246 |
| Total revenues | 458,163 449,081 | 9,082 | 560,670 | 449,177 | 111,493 |
| Operating expenses | (70,933) (68,017) | (2,916) | (73,169) | (69,926) | (3,243) |
| NOI | 387,230 381,064 | 6,166 | 487,501 | 379,251 | 108,250 |
| Straight-line rents | (12,692) (21,664) | 8,972 | (34,371) | (21,677) | (12,694) |
| DFL accretion | (12,202) (14,706) | 2,504 | (12,202) | (14,706) | 2,504 |
| Amortization of above and below market lease intangibles, net | (939) (1,074) | 135 | (533) | (1,074) | 541 |
| Adjusted NOI | $361,397 $343,620 | $17,777 | $440,395 | $341,794 | $98,601 |
| Adjusted NOI % change |  | 5.2% |  |  |  |
| Property count(2) | 311 311 |  | 445 | 311 |  |
| Average capacity (units)(3) | 35,306 35,313 |  | 45,391 | 35,313 |  |
| Average annual rent per unit(4) | $13,668 $12,989 |  | $13,017 | $12,992 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) From our past presentation of SPP for the nine months ended September 30, 2012, we removed a senior housing property from SPP that was sold.

(3) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

(4) Average annual rent per unit includes operating income from properties under a RIDEA structure, which are included based on NOI.

*SPP NOI and Adjusted NOI.* SPP NOI increased primarily as a result of rent increases related to new leases or leases not recognized on a straight-line basis (cash basis) and increased NOI from RIDEA properties; these increases were partially offset by a decline in DFL income as a result of the DFL Portfolio that was placed on a cash basis during the three months ended September 30, 2013. SPP adjusted NOI improved primarily as a result of annual rent increases including increases from properties that were previously transitioned from Sunrise to other operators and increased NOI from RIDEA properties.

*Total Portfolio NOI and Adjusted NOI.* In addition to the impact of our SPP, our total portfolio NOI and adjusted NOI primarily increased as a result of our Blackstone JV Acquisition.

### Post-Acute/Skilled Nursing

|  | SPP 2013 | 2012 | Change | Total Portfolio 2013 | 2012 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $411,912 | $403,209 | $8,703 | $411,912 | $403,209 | $8,703 |
| Operating expenses | (445) | (515) | 70 | (1,947) | (519) | (1,428) |
| NOI | 411,467 | 402,694 | 8,773 | 409,965 | 402,690 | 7,275 |
| Straight-line rents | (271) | (422) | 151 | (271) | (422) | 151 |
| DFL accretion | (53,184) | (56,366) | 3,182 | (53,184) | (56,366) | 3,182 |
| Amortization of above and below market lease intangibles, net | 34 | 34 | — | 34 | 34 | — |
| Adjusted NOI | $358,046 | $345,940 | $12,106 | $356,544 | $345,936 | $10,608 |
| Adjusted NOI % change |  |  | 3.5% |  |  |  |
| Property count(2) | 312 | 312 |  | 312 | 312 |  |
| Average capacity (beds)(3) | 39,826 | 39,850 |  | 39,826 | 39,850 |  |
| Average annual rent per bed | $12,001 | $11,591 |  | $12,001 | $11,591 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) From our past presentation of SPP for the nine months ended September 30, 2012, we removed a post-acute/skilled nursing property from SPP that was sold.

(3) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

*NOI and Adjusted NOI.* SPP and total portfolio NOI and adjusted NOI primarily increased as a result of annual rent escalations.

### Life Science

|  | SPP 2013 | 2012 | Change | Total Portfolio 2013 | 2012 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $180,455 | $179,917 | $538 | $188,309 | $184,600 | $3,709 |
| Tenant recoveries | 31,320 | 30,639 | 681 | 32,779 | 30,969 | 1,810 |
| Total revenues | 211,775 | 210,556 | 1,219 | 221,088 | 215,569 | 5,519 |
| Operating expenses | (35,990) | (34,460) | (1,530) | (41,313) | (38,230) | (3,083) |
| NOI | 175,785 | 176,096 | (311) | 179,775 | 177,339 | 2,436 |
| Straight-line rents | (9,211) | (5,530) | (3,681) | (8,759) | (6,300) | (2,459) |
| Amortization of above and below market lease intangibles, net | 160 | 352 | (192) | 135 | 315 | (180) |
| Lease termination fees | (194) | (175) | (19) | (194) | (175) | (19) |
| Adjusted NOI | $166,540 | $170,743 | $(4,203) | $170,957 | $171,179 | $(222) |
| Adjusted NOI % change |  |  | (2.5)% |  |  |  |
| Property count | 102 | 102 |  | 111 | 110 |  |
| Average occupancy | 92.8% | 91.1% |  | 91.6% | 89.2% |  |
| Average occupied square feet | 6,206 | 6,090 |  | 6,465 | 6,212 |  |
| Average annual rent per occupied square foot | $43 | $45 |  | $44 | $45 |  |

*SPP NOI and Adjusted NOI.* SPP NOI decreased primarily as a result of mark-to-market rent reductions on renewed leases. SPP adjusted NOI decreased primarily as a result of a $4 million rent payment received in February 2012 in connection with a lease amendment and mark-to-market rent reductions, partially offset by annual rent escalations.

*Total Portfolio NOI and Adjusted NOI.* In addition to the impact of our SPP, our total portfolio NOI increased primarily as a result of rents on recent development projects placed in service during 2013 and 2012.

During the nine months ended September 30, 2013, 369,000 square feet of new and renewal leases commenced at an average annual base rent of $28.37 per square foot compared to 236,000 square feet of expiring and terminated leases with an average annual base rent of $36.68 per square foot.

### Medical Office

|  | SPP 2013 | 2012 | Change | Total Portfolio 2013 | 2012 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $199,726 | $200,178 | $(452) | $225,181 | $209,714 | $15,467 |
| Tenant recoveries | 35,771 | 36,205 | (434) | 40,721 | 36,947 | 3,774 |
| Total revenues | 235,497 | 236,383 | (886) | 265,902 | 246,661 | 19,241 |
| Operating expenses | (90,390) | (90,335) | (55) | (105,732) | (98,631) | (7,101) |
| NOI | 145,107 | 146,048 | (941) | 160,170 | 148,030 | 12,140 |
| Straight-line rents | (1,796) | (3,355) | 1,559 | (3,152) | (3,747) | 595 |
| Amortization of above and below market lease intangibles, net | 359 | 207 | 152 | 750 | 240 | 510 |
| Lease termination fees | (26) | (251) | 225 | (26) | (251) | 225 |
| Adjusted NOI | $143,644 | $142,649 | $995 | $157,742 | $144,272 | $13,470 |
| Adjusted NOI % change |  |  | 0.7% |  |  |  |
| Property count(1) | 184 | 184 |  | 208 | 205 |  |
| Average occupancy | 90.6% | 91.2% |  | 90.4% | 91.1% |  |
| Average occupied square feet | 11,479 | 11,542 |  | 12,822 | 12,085 |  |
| Average annual rent per occupied square foot | $27 | $27 |  | $27 | $27 |  |

(1) From our past presentation of SPP for the nine months ended September 30, 2012, we removed a MOB that was placed into redevelopment in 2013, which no longer meets our criteria for SPP as of the date it was placed into redevelopment.

*Total Portfolio NOI and Adjusted NOI.* Total portfolio NOI and adjusted NOI increased primarily as a result of the impact of our MOB acquisitions during 2012.

During the nine months ended September 30, 2013, 1.4 million square feet of new and renewal leases commenced at an average annual base rent of $21.59 per square foot compared to 1.8 million square feet of expiring and terminated leases with an average annual base rent of $22.03 per square foot.

### Hospital

|  | SPP 2013 | 2012 | Change | Total Portfolio 2013 | 2012 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $28,151 | $38,615 | $(10,464) | $31,868 | $40,907 | $(9,039) |
| Tenant recoveries | 1,835 | 1,741 | 94 | 1,835 | 1,740 | 95 |
| Total revenues | 29,986 | 40,356 | (10,370) | 33,703 | 42,647 | (8,944) |
| Operating expenses | (2,819) | (2,722) | (97) | (2,821) | (2,728) | (93) |
| NOI | 27,167 | 37,634 | (10,467) | 30,882 | 39,919 | (9,037) |
| Straight-line rents | 18,556 | (454) | 19,010 | 17,969 | (889) | 18,858 |
| Amortization of above and below market lease intangibles, net | (6,407) | (260) | (6,147) | (6,482) | (334) | (6,148) |
| Adjusted NOI | $39,316 | $36,920 | $2,396 | $42,369 | $38,696 | $3,673 |
| Adjusted NOI % change |  |  | 6.5% |  |  |  |
| Property count(1) | 11 | 11 |  | 13 | 12 |  |
| Average capacity (beds)(2) | 1,448 | 1,453 |  | 1,535 | 1,484 |  |
| Average annual rent per bed | $38,798 | $36,377 |  | $39,253 | $37,218 |  |

(1) From our past presentation of SPP for the nine months ended September 30, 2012, we removed five hospitals from SPP that were sold or classified as held for sale.

(2) Represents capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented. Certain operators in our hospital portfolio are not required under their respective leases to provide operational data.

*SPP and Total Portfolio NOI and Adjusted NOI.* SPP and total portfolio NOI primarily decreased due to a net $12 million correction of an error that reduced previously recognized straight-line rents and to increasing amortization of below market lease intangibles related to our Medical City Dallas hospital. SPP and total portfolio adjusted NOI increased due to annual rent increases, a new lease on our Plano hospital and rents on our Fresno hospital that was placed in service in January 2013.

#### Other Income and Expense Items

#### Interest income

Interest income increased $56 million to $69 million for the nine months ended September 30, 2013. The increase was primarily the result of interest income from the repayment of our Barchester loan in September 2013 (acquired earlier in 2013 at discounted prices), and interest earned from our Four Seasons senior unsecured notes purchased in 2012 and the second tranche of our mezzanine loan facility to Tandem Health Care (see Notes 6 and 9 to the Condensed Consolidated Financial Statements for additional information).

#### Interest expense

Interest expense increased $17 million to $326 million for the nine months ended September 30, 2013. The increase was primarily the result of increases in indebtedness and a decrease of capitalized interest related to assets that were under development in our life science and medical office segments and were placed in service during 2013 and 2012. These increases were partially offset by a reduction in interest rates.

Our exposure to expense fluctuations related to our variable rate indebtedness is substantially mitigated by our interest rate swap contracts. For a more detailed discussion of our interest rate risk, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 3.

#### Depreciation and amortization expense

Depreciation and amortization expense increased $63 million to $317 million for the nine months ended September 30, 2013. The increase was primarily the result of the impact of our senior housing facility and MOB acquisitions during 2012.

#### General and administrative expenses

General and administrative expenses increased $36 million to $90 million for the nine months ended September 30, 2013. The nine months ended September 30, 2013 included $26.4 million of severance-related charges resulting from the termination of our former Chairman, Chief Executive Officer and President (see Note 21 to the Condensed Consolidated Financial Statements for additional information). The increase in general and administrative expenses was also attributable to an insurance recovery of $7 million received in 2012 for previously incurred legal expenses.

#### Impairments

During the nine months ended September 30, 2012, we recognized an impairment of $8 million as a result of the sale of a life science land parcel (see Note 20 to the Condensed Consolidated Financial Statements for additional information). No impairments were recognized during the nine months ended September 30, 2013.

#### Other income, net

Other income, net increased $15 million to $17 million for the nine months ended September 30, 2013. The increase was primarily the result of gains from the sale of marketable equity securities during 2013 of $11 million.

#### Discontinued operations

During the nine months ended September 30, 2013, we sold two properties realizing a gain of $9 million. During the nine months ended September 30, 2012, we sold one property realizing a gain of $3 million.

#### Preferred stock dividends

On March 22, 2012, we announced the redemption of all outstanding shares of preferred stock. On April 23, 2012, we redeemed all outstanding shares of our preferred stock and paid all accrued and unpaid dividends to the redemption date. During the nine months ended September 30, 2012, we incurred a redemption charge of $10.4 million related to the original issuance costs of the preferred stock (this charge is presented as an additional preferred stock dividend in our consolidated income statements).

### Liquidity and Capital Resources

Our principal liquidity needs are to: (i) fund recurring operating expenses, (ii) meet debt service requirements including principal payments and maturities in the last three months of 2013, (iii) fund capital expenditures, including tenant improvements and leasing costs, (iv) fund acquisition and development activities, and (v) make dividend distributions. We anticipate that cash flow from continuing operations over the next 12 months will be adequate to fund our business operations, debt service payments, recurring capital expenditures and cash dividends to shareholders. Capital requirements relating to maturing indebtedness, acquisitions and development activities may require funding from borrowings and/or equity and debt offerings.

Access to capital markets impacts our cost of capital and ability to refinance maturing indebtedness, as well as our ability to fund future acquisitions and development through the issuance of additional securities or secured debt. Credit ratings impact our ability to access capital and directly impact our cost of capital as well. For example, as noted below, our revolving line of credit facility accrues interest at a rate per annum equal to LIBOR plus a margin that depends upon our debt ratings. We also pay a facility fee on the entire revolving commitment that depends upon our debt ratings. As of October 25, 2013, we had a credit rating of BBB+ from Fitch, Baa1 from Moody’s and BBB+ from S&P on our senior unsecured debt securities.

Net cash provided by operating activities was $844 million and $721 million for the nine months ended September 30, 2013 and 2012, respectively. The increase in operating cash flows is primarily the result of the following: (i) the impact of our investments in 2012 and 2013, (ii) assets placed in service during 2012 and 2013 and (iii) rent escalations and resets in 2012 and 2013, which increases were partially offset by increased debt interest payments. Our cash flows from operations are dependent upon the occupancy level of multi-tenant buildings, rental rates on leases, our tenants’ performance on their lease obligations, the level of operating expenses and other factors.

The following are significant investing and financing activities for the nine months ended September 30, 2013:

- made investments of $280 million (development and acquisition of real estate), net of loan repayments of $231 million;
- paid dividends on common stock of $717 million, which were generally funded by cash provided by our operating activities; and
- borrowed $283 million under our unsecured revolving line of credit facility to fund, among other things, the aforementioned investments and repaid $435 million of mortgages and senior unsecured notes.

#### Debt

#### Bank Line of Credit and Term Loan

Our $1.5 billion unsecured revolving line of credit facility (the “Facility”) matures in March 2016 and contains a one-year extension option. Borrowings under the Facility accrue interest at LIBOR plus a margin that depends upon our debt ratings. We pay a facility fee on the entire revolving commitment that depends on our debt ratings. Based on our debt ratings at October 25, 2013, the margin on the Facility was 1.075%, and the facility fee was 0.175%. The Facility also includes a feature that will allow us to increase the borrowing capacity by an aggregate amount of up to $500 million, subject to securing additional commitments from existing lenders or new lending institutions. At September 30, 2013, we had $285 million outstanding under the Facility.

On July 30, 2012, we entered into a credit agreement with a syndicate of banks for a £137 million ($222 million at September 30, 2013) four-year unsecured term loan (the “Term Loan”) that accrues interest at a rate of GBP LIBOR plus 1.20%, based on our current debt ratings. Concurrent with the closing of the Term Loan, we entered into a four-year interest rate swap contract that fixes the rate of the Term Loan at 1.81%, subject to adjustments based on our debt ratings. The Term Loan contains a one-year committed extension option.

The Facility and Term Loan contain certain financial restrictions and other customary requirements. Among other things, these covenants, using terms defined in the agreements, (i) limit the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value to 60%, (ii) limit the ratio of Secured Debt to Consolidated Total Asset Value to 30%, (iii) limit the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value to 60%, (iv) require a minimum Fixed Charge Coverage ratio of 1.5 times and (v) require a formula-determined Minimum Consolidated Tangible Net Worth of $9.2 billion at September 30, 2013. At September 30, 2013, we were in compliance with each of these restrictions and requirements of the Facility and Term Loan.

Our Facility also contains cross-default provisions to other indebtedness of ours, including in some instances, certain mortgages on our properties. Certain mortgages contain default provisions relating to defaults under the leases or operating agreements on the applicable properties by our operators or tenants, including default provisions relating to the bankruptcy filings of such operator or tenant. Although we believe that we would be able to secure amendments under the applicable agreements if a default as described above occurs, such a default may result in significantly less favorable borrowing terms than currently available, material delays in the availability of funding or other material adverse consequences.

#### Senior Unsecured Notes

At September 30, 2013, we had senior unsecured notes outstanding with an aggregate principal balance of $6.6 billion. Interest rates on the notes ranged from 1.22% to 6.98% with a weighted average effective interest rate of 5.10% and a weighted average maturity of five years at September 30, 2013. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions and other customary terms. We believe we were in compliance with these covenants at September 30, 2013.

#### Mortgage Debt

At September 30, 2013, we had $1.4 billion in aggregate principal amount of mortgage debt outstanding is secured by 132 healthcare facilities (including redevelopment properties) with a carrying value of $2.0 billion. Interest rates on the mortgage debt ranged from 0.69% to 8.69% with a weighted average effective interest rate of 6.16% and a weighted average maturity of four years at September 30, 2013.

Mortgage debt generally requires monthly principal and interest payments, is collateralized by real estate assets and is generally non-recourse. Mortgage debt typically restricts transfer of the encumbered assets, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires maintenance of insurance on the assets and includes conditions to obtain lender consent to enter into and terminate material leases. Some of the mortgage debt is also cross-collateralized by multiple assets and may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.

#### Other Debt

At September 30, 2013, we had $78 million of non-interest bearing life care bonds at two of our continuing care retirement communities and non-interest bearing occupancy fee deposits at two of our senior housing facilities, all of which were payable to certain residents of the facilities (collectively, “Life Care Bonds”). The Life Care Bonds are generally refundable to the residents upon the termination of the contract or upon the successful resale of the unit.

#### Debt Maturities

The following table summarizes our stated debt maturities and scheduled principal repayments at September 30, 2013 (in thousands):

| Year | Amount(1) |
| --- | ---: |
| 2013 (Three months) | $414,003 |
| 2014 | 667,042 |
| 2015 | 708,421 |
| 2016 | 1,698,486 |
| 2017 | 1,300,477 |
| Thereafter | 3,721,825 |
|  | 8,510,254 |
| (Discounts) and premiums, net | (27,165) |
|  | $8,483,089 |

(1) Excludes $78 million of other debt that represents Life Care Bonds that have no scheduled maturities.

#### Derivative Instruments

We use derivative instruments to mitigate the effects of interest rate and foreign currency fluctuations on specific forecasted transactions as well as recognized financial obligations or assets. We do not use derivative instruments for speculative or trading purposes.

The following table summarizes our outstanding interest-rate and foreign currency swap contracts as of September 30, 2013 (dollars and GBP in thousands):

| Date Entered | Maturity Date | Hedge Designation | Fixed Rate/Buy Amount | Floating/Exchange Rate Index | Notional/ Sell Amount | Fair Value |
| --- | --- | --- | ---: | --- | ---: | ---: |
| July 2005(1) | July 2020 | Cash Flow | 3.82% | BMA Swap Index | $45,600 | $(6,319) |
| November 2008 | October 2016 | Cash Flow | 5.95% | 1 Month LIBOR+1.50% | $26,600 | $(2,964) |
| July 2012 | June 2016 | Cash Flow | 1.81% | 1 Month GBP LIBOR+1.20% | £137,000 | $1,564 |
| July 2012 | June 2016 | Cash Flow | $68,200 | Buy USD/Sell GBP | £43,500 | $(1,897) |

(1) Represents three interest-rate swap contracts with an aggregate notional amount of $45.6 million which hedge fluctuations in interest payments on variable-rate secured debt due to overall changes in hedged cash flows.

For a more detailed description of our derivative instruments, see Note 19 to the Condensed Consolidated Financial Statements and “Quantitative and Qualitative Disclosures About Market Risk” in Item 3.

#### Equity

At September 30, 2013, we had 456 million shares of common stock outstanding. At September 30, 2013, equity totaled $10.9 billion, and our equity securities had a market value of $18.9 billion.

At September 30, 2013, non-managing members hold an aggregate of 4 million units (“DownREITs”) in four limited liability companies for which we are the managing member. The DownREIT units are exchangeable for an amount of cash approximating the then-current market value of shares of our common stock or, at our option, shares of our common stock (subject to certain adjustments, such as stock splits and reclassifications).

#### Shelf Registration

We have a prospectus that we filed with the U.S. Securities and Exchange Commission (the “SEC”) as part of a registration statement on Form S-3ASR, using a shelf registration process which expires in July 2015. Under the “shelf” process, we may sell any combination of the securities in one or more offerings. The securities described in the prospectus include common stock, preferred stock, depositary shares, debt securities and warrants.

The prospectus only provides a general description of the securities we may offer. The prospectus may not be used to sell securities unless accompanied by a prospectus supplement or a free writing prospectus. Each time we sell securities under the shelf registration, we will provide a prospectus supplement that will contain specific information about the terms of the securities being offered and of the offering. The prospectus supplement may also add, update or change information contained in the prospectus.

We may offer and sell the securities pursuant to the prospectus through underwriters, dealers or agents or directly to purchasers, on a continuous or delayed basis. The securities may also be resold by selling security holders. The prospectus supplement for each offering will describe in detail the plan of distribution for that offering and will set forth the names of any underwriters, dealers or agents involved in the offering and any applicable fees, commissions or discount arrangements. We intend to use the net proceeds from the sales of the securities as set forth in the applicable prospectus supplement, and unless otherwise set forth therein, we will not receive any proceeds if the securities are sold by a selling security holder.

### Funds From Operations (“FFO”)

We believe FFO applicable to common shares, diluted FFO applicable to common shares, and basic and diluted FFO per common share are important supplemental non-GAAP measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that uses historical cost accounting for depreciation could be less informative. The term FFO was designed by the REIT industry to address this issue.

FFO is defined as net income applicable to common shares (computed in accordance with GAAP), excluding gains or losses from acquisition and dispositions of depreciable real estate or related interests, impairments of, or related to, depreciable real estate, plus real estate and DFL depreciation and amortization, with adjustments for joint ventures. Adjustments for joint ventures are calculated to reflect FFO on the same basis. FFO does not represent cash generated from operating activities in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net income. We compute FFO in accordance with the current National Association of Real Estate Investment Trusts’ (“NAREIT”) definition; however, other REITs may report FFO differently or have a different interpretation of the current NAREIT definition from us. In addition, we present FFO before the impact of severance-related charges, litigation settlement charges, preferred stock redemption charges, impairments (recoveries) of non-depreciable assets and merger-related items (defined below) (“FFO as adjusted”). Management believes FFO as adjusted is a useful alternative measurement. This measure is a modification of the NAREIT definition of FFO and should not be used as an alternative to net income (determined in accordance with GAAP).

Details of certain items that affect comparability are discussed under “Results of Operations” above. The following is a reconciliation of net income applicable to common shares, the most direct comparable financial measure calculated and presented in accordance with GAAP, to FFO and FFO as adjusted (in thousands, except per share data):

|  | Three Months Ended September 30, 2013 | 2012 | Nine Months Ended September 30, 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| Net income applicable to common shares | $233,282 | $195,629 | $676,412 | $572,352 |
| Depreciation and amortization of real estate, in-place lease and other intangibles: |  |  |  |  |
| Continuing operations | 104,859 | 87,170 | 317,430 | 254,463 |
| Discontinued operations | 1,433 | 2,969 | 4,346 | 11,876 |
| DFL depreciation | 3,631 | 3,234 | 10,589 | 9,426 |
| Gain on sales of real estate | (8,298) | — | (9,185) | (2,856) |
| Equity income from unconsolidated joint ventures | (13,892) | (13,396) | (44,278) | (42,803) |
| FFO from unconsolidated joint ventures | 16,642 | 16,043 | 52,539 | 50,495 |
| Noncontrolling interests’ and participating securities’ share in earnings | 3,576 | 3,414 | 10,955 | 11,224 |
| Noncontrolling interests’ and participating securities’ share in FFO | (5,162) | (4,821) | (15,569) | (15,512) |
| FFO applicable to common shares | 336,071 | 290,242 | 1,003,239 | 848,665 |
| Distributions on dilutive convertible units | 3,302 | 3,148 | 9,966 | 9,397 |
| Diluted FFO applicable to common shares | $339,373 | $293,390 | $1,013,205 | $858,062 |
| Diluted FFO per common share | $0.73 | $0.67 | $2.20 | $2.01 |
| Weighted average shares used to calculate diluted FFO per common share | 462,082 | 437,043 | 461,403 | 427,388 |
| Impact of adjustments to FFO: |  |  |  |  |
| Severance-related charges(1) | $26,374 | $— | $26,374 | $— |
| Preferred stock redemption charge(2) | — | — | — | 10,432 |
| Impairments(3) | — | 7,878 | — | 7,878 |
|  | $26,374 | $7,878 | $26,374 | $18,310 |
| FFO as adjusted applicable to common shares | $362,445 | $298,120 | $1,029,613 | $866,975 |
| Distributions on dilutive convertible units and other | 3,247 | 3,127 | 9,907 | 9,345 |
| Diluted FFO as adjusted applicable to common shares | $365,692 | $301,247 | $1,039,520 | $876,320 |
| Diluted FFO as adjusted per common share | $0.79 | $0.69 | $2.25 | $2.05 |
| Weighted average shares used to calculate diluted FFO as adjusted per common share | 462,082 | 437,043 | 461,403 | 427,388 |

(1) The Company’s Board of Directors, after deliberations during the third quarter 2013, terminated its former Chairman, Chief Executive Officer and President on October 2, 2013. As a result of the termination, we incurred severance-related charges of $26.4 million that include: (i) the acceleration of $16.7 million of deferred compensation for restricted stock units and options that vested upon termination; and (ii) severance payments and other costs of approximately $9.7 million. See Note 21 to the Condensed Consolidated Financial Statements for additional information.

(2) In connection with the redemption of our preferred stock, we incurred a one-time, non-cash redemption charge of $10.4 million related to the original issuance costs of the preferred stock.

(3) The impairment charge of $7.9 million related to the sale of a land parcel in our life science segment.

### Off-Balance Sheet Arrangements

We own interests in certain unconsolidated joint ventures as described under Note 7 to the Condensed Consolidated Financial Statements. Except in limited circumstances, our risk of loss is limited to our investment in the joint venture and any outstanding loans receivable. In addition, we have certain properties which serve as collateral for debt that is owed by a previous owner of certain of our facilities, as described under Note 11 to the Condensed Consolidated Financial Statements. Our risk of loss for these certain properties is limited to the outstanding debt balance plus penalties, if any. We have no other material off-balance sheet arrangements that we expect would materially affect our liquidity and capital resources except those described below under “Contractual Obligations.”

### Contractual Obligations

The following table summarizes our material contractual payment obligations and commitments at September 30, 2013 (in thousands):

|  | Total(1) | Less than One Year | 2014-2015 | 2016-2017 | More than Five Years |
| --- | ---: | ---: | ---: | ---: | ---: |
| Line of credit | $285,000 | $— | $— | $285,000 | $— |
| Term loan(2) | 221,748 | — | — | 221,748 | — |
| Senior unsecured notes | 6,587,000 | 400,000 | 887,000 | 1,650,000 | 3,650,000 |
| Mortgage debt | 1,416,506 | 14,003 | 488,463 | 842,215 | 71,825 |
| Construction loan commitments(3) | 37,389 | 7,740 | 29,649 | — | — |
| Development commitments(4) | 20,943 | 17,433 | 3,510 | — | — |
| Ground and other operating leases | 220,789 | 1,711 | 11,522 | 8,014 | 199,542 |
| Interest(5) | 2,192,980 | 51,629 | 725,312 | 528,282 | 887,757 |
| Total | $10,982,355 | $492,516 | $2,145,456 | $3,535,259 | $4,809,124 |

(1) Excludes $78 million of other debt that represents Life Care Bonds that have no scheduled maturities.

(2) Represents £137 million translated into U.S. dollars.

(3) Represents commitments to finance development projects and related working capital financings.

(4) Represents construction and other commitments for developments in progress.

(5) Interest on variable-rate debt is calculated using rates in effect at September 30, 2013.

### Inflation

Our leases often provide for either fixed increases in base rents or indexed escalators, based on the Consumer Price Index or other measures, and/or additional rent based on increases in the tenants’ operating revenues. Most of our MOB leases require the tenant to pay a share of property operating costs such as real estate taxes, insurance and utilities. Substantially all of our senior housing, life science, post-acute/skilled nursing and hospital leases require the operator or tenant to pay all of the property operating costs or reimburse us for all such costs. We believe that inflationary increases in expenses will be offset, in part, by the operator or tenant expense reimbursements and contractual rent increases described above.

### Recent Accounting Pronouncements

See Note 2 to the Condensed Consolidated Financial Statements for the impact of new accounting standards. There are no accounting pronouncements that have been issued, but not yet adopted by us, that we believe will materially impact our condensed consolidated financial statements.

## Market risk

As filed, 4,391 characters.

We use derivative financial instruments in the normal course of business to mitigate interest rate and foreign currency risk. We do not use derivative financial instruments for speculative or trading purposes. Derivatives are recorded on the condensed consolidated balance sheets at their fair value. See Note 19 to the Condensed Consolidated Financial Statements for additional information.

To illustrate the effect of movements in the interest rate and foreign currency markets, we performed a market sensitivity analysis on our hedging instruments. We applied various basis point spreads to the underlying interest rate curves and foreign currency exchange rates of the derivative portfolio in order to determine the instruments’ change in fair value. Assuming a one percentage point change in the underlying interest rate curve and foreign currency exchange rates, the estimated change in fair value of each of the underlying derivative instruments would not exceed $6 million. See Note 19 to the Condensed Consolidated Financial Statements for additional analysis details.

*Interest Rate Risk.* At September 30, 2013, we are exposed to market risks related to fluctuations in interest rates on the following: (i) $285 million of variable-rate line of credit borrowings, (ii) $25 million of variable-rate senior unsecured notes and (iii) $15 million of variable-rate mortgage debt payable (excludes $72 million of variable-rate mortgage notes that have been hedged through interest-rate swap contracts) that are partially offset by properties with a gross value of $83 million that are subject to leases where the payments fluctuate with changes in LIBOR. Additionally, our exposure to market risks related to fluctuations in interest rates excludes our GBP denominated $222 million (£137 million) variable-rate Term Loan that has been hedged through interest-rate swap contracts.

Interest rate fluctuations will generally not affect our future earnings or cash flows on our fixed rate debt and assets unless such instruments mature or are otherwise terminated. However, interest rate changes will affect the fair value of our fixed rate instruments. Conversely, changes in interest rates on variable rate debt and investments would change our future earnings and cash flows, but not significantly affect the fair value of those instruments. Assuming a one percentage point increase in the interest rate related to the variable-rate investments and variable-rate debt, and assuming no other changes in the outstanding balance as of September 30, 2013, our annual interest expense would increase by approximately $2 million, or less than $0.01 per common share on a diluted basis.

*Foreign Currency Risk.* At September 30, 2013, our exposure to foreign currency exchange rates relates to forecasted interest receipts from our GBP denominated senior unsecured notes (see additional discussion of the Four Seasons senior unsecured notes in Note 9 to the Condensed Consolidated Financial Statements). Our foreign currency exchange exposure is mitigated by the forecasted interest and principal payments from our GBP denominated unsecured Term Loan (see Note 10 to the Condensed Consolidated Financial Statements for additional information), and a foreign currency swap contract for approximately 85% of the forecasted interest receipts from our Four Seasons senior unsecured notes through their non-call period, which ends on June 15, 2016.

*Market Risk.* We have investments in marketable debt securities classified as held-to-maturity, because we have the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are recorded at amortized cost and adjusted for the amortization of premiums and discounts through maturity. We consider a variety of factors in evaluating an other-than-temporary decline in value, such as: the length of time and the extent to which the market value has been less than our current adjusted carrying value; the issuer’s financial condition, capital strength and near-term prospects; any recent events specific to that issuer and economic conditions of its industry; and our investment horizon in relationship to an anticipated near-term recovery in the market value, if any. At September 30, 2013, the fair value and adjusted carrying value of marketable debt securities were $273 million and $239 million, respectively.

## Controls and procedures

As filed, 2,284 characters.

*Disclosure Controls and Procedures.* We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Also, we have investments in certain unconsolidated entities. Our disclosure controls and procedures with respect to such entities are substantially more limited than those we maintain with respect to our consolidated subsidiaries.

As required by Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2013. Based upon that evaluation, our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) concluded that our disclosure controls and procedures were effective at the reasonable assurance level.

*Changes in Internal Control Over Financial Reporting.* There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 161 characters.

There are no material changes to the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2012.

Filed Nov 4, 2013.
Source: SEC EDGAR, the filing index for accession 0001104659-13-080260. Last ingested by Listed: Nov 14, 2026, 21:09 ET. No prices; not investment advice.
